Antigen-Specific Tregulatory Cells and the Development of a T1D Vaccine: Clinically Derived Antigen-Specific Peptide-Based Modalities
Time: 1:30 pm
day: Conference Day One
Details:
• Review of clinical progress with Tregualtory cell therapies
• Development of a powerful Peptidomic and cell based assay platform for validating disease specific peptides from clinical samples
• Development of antigen-specific Tregulatory cell therapy and mRNA encoded peptide vaccine for Type 1 diabetes and other autoimmune diseases
